Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Journal
The Lancet
ISSN
0140-6736
Date Issued
2022
Author(s)
Daniel R Feikin
Melissa M Higdon
Laith J Abu-Raddad
Nick Andrews
Yair Goldberg
Michelle J Groome
Amit Huppert
Katherine L O'Brien
Peter G Smith
Annelies Wilder-Smith
Scott Zeger
Maria Deloria Knoll
Minal K Patel
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Cite this document
Feikin, D. R., Higdon, M. M., Abu-Raddad, L. J., Andrews, N., Araos, R., Goldberg, Y., Groome, M. J., Huppert, A., O’Brien, K. L., Smith, P. G., Wilder-Smith, A., Zeger, S., Deloria Knoll, M., & Patel, M. K. (2022). Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression. The Lancet, 399(10328), 924-944. https://doi.org/10.1016/S0140-6736(22)00152-0
Subjects
ad26covs1
;
bnt162 vaccine
;
covid-19
;
covid-19 vaccines
;
humans
;
immunization schedule
;
immunization, secondary
;
sars-cov-2
;
time factors
;
ad26.cov2.s vaccine
;
elasomeran
;
sars-cov-2 vaccine
;
tozinameran
;
vaxzevria
;
age
;
article
;
breakthrough infection
;
clinical outcome
;
coronavirus disease 2019
;
disease severity
;
dose time effect relation
;
drug efficacy
;
human
;
immunity
;
randomized controlled trial (topic)
;
sars-cov-2 delta
;
severe acute respiratory syndrome coronavirus 2
;
systematic review
;
vaccination
;
drug therapy
;
immunization
;
immunology
;
isolation and purification
;
meta analysis
;
prevention and control
;
secondary immunization
;
time factor